Federation des caisses Desjardins du Quebec
ZVRA icon

Federation des caisses Desjardins du Quebec’s Zevra Therapeutics ZVRA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.45K Buy
450
+150
+50% +$1.67K ﹤0.01% 2533
2026
Q1 		$2.8K Sell
300
-50
-14% -$451 ﹤0.01% 2615
2025
Q4 		$3.14K Buy
350
+300
+600% +$2.84K ﹤0.01% 2535
2025
Q3 		$476 Buy
+50
New +$501 ﹤0.01% 2731

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ZVRA Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Zevra Therapeutics (ZVRA) stake by 50% in Q2 2026, buying an estimated $1.67K and bringing the position to 450 shares worth $6.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Federation des caisses Desjardins du Quebec first reported a position in ZVRA in Q3 2025 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 450 shares of Zevra Therapeutics worth $6.45K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 150 Zevra Therapeutics shares in Q2 2026, an estimated $1.67K.
  • Zevra Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2533 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Zevra Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.